These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 37143724)

  • 1. Role of sex hormones in diabetic nephropathy.
    Liu J; Liu Z; Sun W; Luo L; An X; Yu D; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1135530. PubMed ID: 37143724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy.
    Wang S; Qin S; Cai B; Zhan J; Chen Q
    Front Endocrinol (Lausanne); 2023; 14():932649. PubMed ID: 37522131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.
    Jin Q; Liu T; Qiao Y; Liu D; Yang L; Mao H; Ma F; Wang Y; Peng L; Zhan Y
    Front Immunol; 2023; 14():1185317. PubMed ID: 37545494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Nephropathy: a Tangled Web to Unweave.
    Magee C; Grieve DJ; Watson CJ; Brazil DP
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):579-592. PubMed ID: 28956186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms.
    Liu XJ; Hu XK; Yang H; Gui LM; Cai ZX; Qi MS; Dai CM
    Am J Chin Med; 2022; 50(7):1739-1779. PubMed ID: 36222120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy.
    Chang DY; Li MR; Yu XJ; Wang SX; Chen M; Zhao MH
    Front Endocrinol (Lausanne); 2021; 12():761386. PubMed ID: 34764941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities.
    Raval N; Kumawat A; Kalyane D; Kalia K; Tekade RK
    Drug Discov Today; 2020 May; 25(5):862-878. PubMed ID: 31981791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.
    Samsu N
    Biomed Res Int; 2021; 2021():1497449. PubMed ID: 34307650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy.
    Ayinde KS; Olaoba OT; Ibrahim B; Lei D; Lu Q; Yin X; Adelusi TI
    Life Sci; 2020 Nov; 261():118455. PubMed ID: 32956662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
    Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
    Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy.
    Li J; Li L; Zhang Z; Chen P; Shu H; Yang C; Chu Y; Liu J
    Front Immunol; 2023; 14():1294317. PubMed ID: 38111578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting inflammation in diabetic nephropathy: a tale of hope.
    Moreno JA; Gomez-Guerrero C; Mas S; Sanz AB; Lorenzo O; Ruiz-Ortega M; Opazo L; Mezzano S; Egido J
    Expert Opin Investig Drugs; 2018 Nov; 27(11):917-930. PubMed ID: 30334635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Dendritic Cell in Diabetic Nephropathy.
    Kim H; Kim M; Lee HY; Park HY; Jhun H; Kim S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats.
    Zhang L; Yang Z; Zhao Y; Yang X; Meng X; Liu J; Liu Y; Yan C; Yan D
    Sci Rep; 2020 Feb; 10(1):2040. PubMed ID: 32029775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
    Liu XQ; Jiang L; Lei L; Nie ZY; Zhu W; Wang S; Zeng HX; Zhang SQ; Zhang Q; Yard B; Wu YG
    Clin Sci (Lond); 2020 Dec; 134(23):3175-3193. PubMed ID: 33241846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy.
    Zhang Q; Yang M; Xiao Y; Han Y; Yang S; Sun L
    Curr Med Chem; 2021; 28(5):1003-1024. PubMed ID: 31701843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy.
    Wang E; Wang L; Ding R; Zhai M; Ge R; Zhou P; Wang T; Fang H; Wang J; Huang J
    Pharmacol Res; 2020 Jul; 157():104831. PubMed ID: 32339782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway.
    Ma L; Wu F; Shao Q; Chen G; Xu L; Lu F
    Drug Des Devel Ther; 2021; 15():3207-3221. PubMed ID: 34321869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.